tiprankstipranks
Trending News
More News >
Editas Medicine Inc (GB:0IFK)
LSE:0IFK
UK Market

Editas Medicine (0IFK) Technical Analysis

Compare
2 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Editas Medicine Inc’s (0IFK) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Editas Medicine Inc is a Buy.
Editas Medicine Inc’s (0IFK) 20-Day exponential moving average is 1.44, while Editas Medicine Inc’s (0IFK) share price is $1.44, making it a Buy.
Editas Medicine Inc’s (0IFK) 50-Day exponential moving average is 1.44, while Editas Medicine Inc’s (0IFK) share price is $1.44, making it a Sell.

Editas Medicine (0IFK) Pivot Points

May 09, 2025, 11:58 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.29
1.31
1.35
1.37
1.41
1.43
1.47
Fibonacci
1.31
1.33
1.35
1.37
1.39
1.41
1.43
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Editas Medicine (0IFK) Moving Averages

May 09, 2025, 11:58 PM
Period
Simple
Exponential
MA5
1.49Sell
1.46Sell
MA10
1.52Sell
1.47Sell
MA20
1.41Buy
1.44Buy
MA50
1.44Sell
1.44Sell
MA100
1.42Buy
1.69Sell
MA200
2.43Sell
2.62Sell
Editas Medicine Inc’s (0IFK) 10-Day exponential moving average is 1.47, while Editas Medicine Inc’s (0IFK) share price is $1.44, making it a Sell.
Editas Medicine Inc’s (0IFK) 100-Day exponential moving average is 1.69, while Editas Medicine Inc’s (0IFK) share price is $1.44, making it a Sell.
Editas Medicine Inc’s (0IFK) stock price is $1.44 and Editas Medicine Inc’s (0IFK) 50-day simple moving average is 1.44, creating a Sell signal.
Editas Medicine Inc’s (0IFK) stock price is $1.44 and Editas Medicine Inc’s (0IFK) 100-day simple moving average is 1.42, creating a Buy signal.
Editas Medicine Inc’s (0IFK) stock price is $1.44 and Editas Medicine Inc’s (0IFK) 200-day simple moving average is 2.43, creating a Sell signal.

Editas Medicine (0IFK) Technical Indicators

May 09, 2025, 11:58 PM
Name
Value
Implied Action
RSI (14)
50.66
Neutral
STOCH (9,6)
16.66
Buy
STOCHRSI (14)
31.76
Neutral
MACD (12,26)
0.04
Buy
ADX (14)
21.51
Neutral
Williams %R
-60.54
Buy
CCI (14)
1.94
Neutral
ATR (14)
0.15
-
Ultimate Oscillator
50.98
Neutral
ROC
8.20
Buy
Editas Medicine Inc’s (0IFK) Relative Strength Index (RSI) is 50.66, creating a Neutral signal.
Editas Medicine Inc’s (0IFK) Trend Strength Indicator (ADX) is 21.51, creating a Neutral signal.
Editas Medicine Inc’s (0IFK) Commodity Channel Index (CCI) is 1.94, creating a Neutral signal.
Editas Medicine Inc’s (0IFK) Price Rate of Change (ROC) is 8.20, creating a Buy signal.

FAQ

Is 0IFK a Buy, Hold, or Sell?
Based on 0IFK’s technical indicators, 0IFK is a Sell.
    What is 0IFK’s RSI (14)?
    0IFK’s RSI (14) is 50.66, which suggests 0IFK is a Neutral.
      What is 0IFK’s MACD?
      0IFK’s MACD is 0.04, which suggests 0IFK is a Buy.
        What is 0IFK’s 5-day moving average?
        0IFK’s 5-day moving average is 1.49, which suggests 0IFK is a Sell.
          What is 0IFK’s 20-day moving average?
          0IFK 20-day moving average is 1.41, which suggests 0IFK is a Buy.
            What is 0IFK’s 50-day moving average?
            0IFK’s 50-day moving average is 1.44, which suggests 0IFK is a Sell.
              What is 0IFK’s 200-day moving average?
              0IFK’s 200-day moving average is 2.43, which suggests 0IFK is a Sell.
                What is 0IFK’s Williams % R (14)?
                0IFK’s Williams % R (14) is -60.54, which suggests 0IFK is a Buy.
                  What is 0IFK’s CCI (14)?
                  0IFK’s CCI (14) is 1.94, which suggests 0IFK is a Neutral.
                    What is the share price of Editas Medicine Inc?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis